Status:
UNKNOWN
The Efficacy of Health Partnership Program for Cancer Patients
Lead Sponsor:
National Cancer Center, Korea
Collaborating Sponsors:
Samsung Medical Center
Seoul National University Hospital
Conditions:
Breast Cancer
Colon Cancer
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The Objectives of this study is 1. To evaluate the efficacy for exercise, diet, and posttraumatic growth as a result of participating in tailored program (Health Partnership Program) for 24 weeks 2. ...
Detailed Description
\*\*\*Background Improving cancer patients' quality of life has been increasing subject of research for several years. Especially, the patients and their families who are needed to deal with specific...
Eligibility Criteria
Inclusion
- Adult(≥ 20 years)
- Within 24 months of completion of primary treatment with curative intent (Surgery, radiotherapy, chemotherapy)
- Breast, cervical, colorectal (except rectal cancer), lung, and stomach cancer
- More than two problematic areas among exercise, diet (Fruit \& Vegetable: F\&V), and posttraumatic growth(exercise \< 150min/week, ≥ 3mets, F\&V \< 5/day, PTGI \< 71)
Exclusion
- Evidence of secondary tumor, metastasis and recurrence
- Patients undergoing or planning surgery, radiation therapy or chemotherapy
- Not Korean speaking and reading (Not communication with Korean)
- Not understanding of the study purpose and not written informed consent
- Participants who have an similar study experience
- Major health problem in which exercise/nutrition intervention is contraindicated at the discretion of clinician; cardiovascular disease (congestive heart failure, angina), pulmonary disease (chronic obstructive pulmonary disease, restrictive pulmonary disease), uncontrolled hypertension, poorly controlled diabetes and severe musculoskeletal disease and so on
- Sign of infection (body temperature ≥ 37.2℃ or WBC ≥ 11,000)
- Being pregnant
- Thrombocytopenia (platelet count ≤ 100,000/mcl)
- Anemia (Hb ≤ 10g/dL)
- SGOT or SGPT \> 40 IU/L
- Creatinine \> 1.2 mg/dL
- Severe psychiatric disorder (psychotic disorder, major depression and so on) or suicidal tendencies
- dyspnea
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT01527409
Start Date
February 1 2012
End Date
June 1 2013
Last Update
February 7 2012
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Boondang Hospital
Boondang, Gyunggi, South Korea
2
National Cancer Center
Goyang, Gyunggi, South Korea
3
Ajou University Medical Center
Suwon, Gyunggi, South Korea
4
Keimyng University Dongsan Center
Daegu, South Korea